Teligent Inc (USD)
TLGT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.60 | 0.66
52-Wk Range0.42 | 1.90
Last Close0.62
Mkt Cap (m)33.51
Dividend yield-
ISINUS87960W1045
Volume137,996
Exchange VenueNAS

Company Profile

Teligent Inc is a specialty generic pharmaceutical company. It markets and sells generic topical and branded generic injectable pharmaceutical products in the United States and Canada.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales0.50
P/CF-
Rev Growth (3 year avg)14.18
EPS Growth (3 year avg)-
Operating Margin % -22.92
Net Margin %-55.05
Return on Equity-114.78
Debt/Equity8.36

Legal Documents

Prospectus
en 27/06/2014
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)183444676766
Operating Income (m)4-33-12-15
Net Income (m)57-12-15-36
Basic EPS-0.030.110.13-0.23-0.28-0.68
Avg. Diluted Shares Outstanding (m)446467535354
Balance Sheet
USD201320142015201620172018
Current Assets (m)111771171036548
Non Current Assets (m)5206880125143
Total Assets (m)15197185183190191
Current Liabilities (m)51311152433
Total Liabilities (m)------
Total Equity (m)73967574518
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-1-4-161-13
Capital Expenditure (m)-1-41-19-40-25
Figures are quoted in USD unless stated otherwise
0.01 (1.98%)
$
0.63
Last Price